ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Extends Revenue Momentum And Raises Full‑Year Guidance
![]() |
ANI Pharmaceuticals shows accelerating top‑line momentum alongside ample liquidity, while technical signals suggest a near‑term continuation of the recent directional move. |










